This NDC is on FDA's drug shortage list (posted Jul 26, 2023)

Product Information

METHYLPHENIDATE ER 27 MG TAB is a generic product labeled by Actavis Pharma, Inc., priced at $0.6446 per EA under NDC 62037073401. Its NADAC has been published 382 times since May 1, 2019.

FDA first approved this application on Mar 22, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE ER 27 MG TAB

Methylphenidate Hydrochloride
$0.6446per EA
DEA Schedule CII

Strength

27 mg/1

NDC

62037073401

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076772

FDA Approved

3/22/2018

TE Code

AB

On Market Since

3/4/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER 27 MG TAB has been published 382 times since May 1, 2019, and over the history we have for it it has declined 88.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6446 per EA
All-time high$5.6856 (May 15, 2019)
All-time low$0.5744 (Jul 20, 2022)
52-week high$0.6919
52-week low$0.6242
Median price$0.8272
Average price$1.3725
Largest weekly change+64.7% (Feb 1, 2023)
Weeks tracked382
Tracking sinceMay 1, 2019

Price History

1W

+2.1%

1M

+2.1%

3M

+1.4%

6M

+3.2%

1Y

-6.8%

3Y

-20.3%

5Y

-45.9%

All

-88.7%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER 27 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 27 MG TAB, manufactured by Actavis Pharma, Inc., is $0.6446 per EA (NDC 62037073401), effective Aug 19, 2026.

How has the price of METHYLPHENIDATE ER 27 MG TAB changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER 27 MG TAB has declined 88.7%. It has been tracked across 382 weekly CMS publications since May 1, 2019.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 27 MG TAB?

Since May 1, 2019, the NADAC for METHYLPHENIDATE ER 27 MG TAB has ranged from a low of $0.5744 (Jul 20, 2022) to a high of $5.6856 (May 15, 2019), with a median of $0.8272 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER 27 MG TAB?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE ER 27 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPHENIDATE ER 27 MG TAB?

METHYLPHENIDATE ER 27 MG TAB (NDC 62037073401) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.

Is METHYLPHENIDATE ER 27 MG TAB in shortage?

Yes — NDC 62037073401 is currently listed in FDA's drug shortage database (posted Jul 26, 2023).